Barclays’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 4373 |
|
|
2025
Q1 | $0 | Sell |
3
-64
| -96% | – | ﹤0.01% | 4396 |
|
|
2024
Q4 | $0 | Buy |
67
+64
| +2,133% | – | ﹤0.01% | 4372 |
|
|
2024
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 4333 |
|
|
2024
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 4201 |
|
|
2024
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 4174 |
|
|
2023
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 4219 |
|
|
2023
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 4270 |
|
|
2023
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 4270 |
|
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 4313 |
|
|
2022
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4392 |
|